Oxandrolone in AIDS-wasting myopathy

AIDS
J R BergerR Dudley

Abstract

To evaluate oxandrolone, an oral anabolic steroid with potent anabolic activity and minimal androgenic effects, for the treatment of AIDS-associated myopathy and wasting. In a multicenter, double-blind study, 63 HIV-seropositive men with > 10% loss of body weight were randomized to receive either placebo, 5 mg/day oxandrolone, or 15 mg/day oxandrolone for 16 weeks. Body weight, neuromuscular evaluation, and measures of well-being were repeatedly assessed. Patients who received 15 mg/day oxandrolone showed weight gain throughout the 16-week treatment period. Overall, the 5 mg/day oxandrolone group maintained their weight gain over the 16-week period, whereas the placebo group showed continual weight loss. At week 16, significantly more patients in the 15 mg/day dose group reported increases in appetite and activity than those receiving placebo. There were no consistent, dose-related, statistically significant differences from baseline in laboratory values or adverse events. Oxandrolone, at a dose of either 5 mg/day or 15 mg/day, in contrast to placebo, had a positive impact on the weight and well-being of HIV-seropositive patients suffering from wasting and weakness. Measurable improvement in muscle strength was not noted at the...Continue Reading

Citations

Dec 21, 2000·Current Oncology Reports·K A Nelson
Apr 20, 2001·Current Pain and Headache Reports·K A Nelson
Nov 26, 2003·Burns : Journal of the International Society for Burn Injuries·Robert H Demling, Leslie DeSanti
Aug 7, 2002·International Journal of Cardiology·Kathleen Mulligan, Morris Schambelan
Sep 27, 2001·Endocrinology and Metabolism Clinics of North America·S BhasinM Javanbakht
Oct 24, 1998·Nutrition·C S Ball
May 20, 1999·Baillière's Clinical Endocrinology and Metabolism·A S Dobs
Aug 26, 2006·Nature Clinical Practice. Endocrinology & Metabolism·Shalender BhasinJames T Dalton
Jun 3, 1999·The New England Journal of Medicine·C Corcoran, S Grinspoon
Mar 5, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D Mkaya MwamburiChristine A Wanke
Aug 1, 1997·AIDS Patient Care and STDs·M Cianfrocca, J H Von Roenn
Apr 17, 2001·Annals of Surgery·D W HartD N Herndon
Dec 24, 1997·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·J CofrancescoA S Dobs
Jul 17, 1998·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·F SattlerR Horton
Mar 17, 1999·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·D M SegalP Shapshak
Aug 24, 1999·Current Opinion in Clinical Nutrition and Metabolic Care·E C Creutzberg, A M Schols
Aug 26, 2006·Plastic and Reconstructive Surgery·Mustafa AkyurekUNKNOWN Plastic Surgery Educational Foundation DATA Committee
Jan 30, 2004·The Journal of Trauma·Suchmor ThomasDavid N Herndon
Feb 6, 2010·Critical Care Medicine·Lindsay-Rae B WeitzelPaul E Wischmeyer
Feb 19, 2010·The American Journal of Clinical Nutrition·Norleena P GullettThomas R Ziegler
Jan 1, 2010·Acta Crystallographica. Section E, Structure Reports Online·Abdul Rauf RazaM Nawaz Tahir
Nov 1, 2002·The Lancet Infectious Diseases·Anthony Kong, Polly Edmonds
Mar 15, 2005·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Abby H ShevitzSherwood L Gorbach
Mar 17, 2006·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Carl GrunfeldShalender Bhasin
Dec 29, 2000·Journal of Acquired Immune Deficiency Syndromes : JAIDS·D I Abrams
Apr 3, 2012·Journal of the American College of Surgeons·Laura J PorroCeleste C Finnerty
Apr 13, 2000·Mayo Clinic Proceedings·P M NemechekM S Gottlieb
Nov 7, 2006·Clinics in Plastic Surgery·Richard N Sherman
Apr 18, 2009·Journal of Surgical Oncology·Matthew R Bower, Robert C G Martin
Jul 23, 2008·Developmental Disabilities Research Reviews·Jason C G Halford, Joanne A Harrold
May 2, 2014·Pharmacotherapy·Melissa Badowski, Neha Sheth Pandit
Aug 10, 2004·Surgery·Kevin D MurphyDavid N Herndon
Feb 12, 2000·The Journal of the Association of Nurses in AIDS Care : JANAC·M M Abbaticola
Nov 11, 2008·Biochimica Et Biophysica Acta·A J MurtonP L Greenhaff
Jan 28, 2014·Korean journal of urology·Jane AshbyHossein Sadeghi-Nejad

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cachexia & Brown Fat

Cachexia is a condition associated with progressive weight loss due to severe illness. In cancer patients, it is proposed to occur as a result of tumor-induced energy wasting. Several proteins have been implicated in browning and depletion of white adipose tissue. Here is the latest research on cachexia and brown fat.

Cardiac Cachexia

Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.